Aditya Juloori

University of Chicago — United States

Medicine · Health Sciences

21h-index2.4kcitations170works18.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(59), Lung Cancer Diagnosis and Treatment(36), Lung Cancer Research Studies(26), Lung Cancer Treatments and Mutations(25), Brain Metastases and Treatment(24)

Publications165 total

Practice Patterns in Management of Low‐ to Intermediate‐Grade Salivary Gland Carcinoma: A Multi‐Institutional Study
Laryngoscope Investigative Otolaryngology·2025Open Access
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 7.2025
Journal of the National Comprehensive Cancer Network·2025· 15 cited
Spurn the Scorecard: Personalized Dose Constraints for Head and Neck Radiotherapy to Minimize Treatment Toxicity
International Journal of Radiation Oncology*Biology*Physics·2025
Total Radiotherapy Treatment Time in Head and Neck Cancer Patients Treated with IGRT in a Latin American Middle-Income Country
International Journal of Radiation Oncology*Biology*Physics·2025Open Access
Stage III Non–Small-Cell Lung Cancer
2025
Supplementary Table 1 from Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
2025Open Access
Supplementary Figure 1 from Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
2025Open Access
Laryngeal Cancer
2025
Supplemental Table 2 from Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
2025Open Access
Supplemental Table 4 from Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
2025Open Access
Supplemental Table 3 from Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
2025Open Access
Data from Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
2025Open Access
Oropharynx Cancer
2025
Corrigendum to “Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas”. [Oral Oncol. 163 (2025) 107207]
Oral Oncology·2025
Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network·2025· 11 cited
Circulating tumor HPV-DNA dynamics and neoadjuvant chemotherapy with or without nivolumab in viral-mediated oropharyngeal cancer.
Journal of Clinical Oncology·2025· 1 cited
Functional and survival outcomes in HPV positive oropharyngeal squamous cell cancer treated with response-adaptive de-escalation: A pooled analysis.
Journal of Clinical Oncology·2025
Real-world surgical and treatment patterns after neoadjuvant checkpoint inhibition in US patients with stage II/III non-small cell lung cancer.
Journal of Clinical Oncology·2025
Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
Clinical Cancer Research·2025· 4 citedOpen Access
Advances in Head and Neck Cancers: Nasopharyngeal and Oral Cancers
Journal of the National Comprehensive Cancer Network·2025· 1 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Everett E. Vokes(15), Alexander T. Pearson(14), Ari J. Rosenberg(14), Samuel T. Chao(12), Nishant Agrawal(12), Gregory M.M. Videtic(11), Evgeny Izumchenko(10), John H. Suh(9), Elizabeth A. Blair(9), Mark W. Lingen(9), Erin S. Murphy(8), Chirag Shah(8), Daniel Thomas Ginat(8), Daniel J. Haraf(8), N.M. Woody(8), Joe Y. Chang(7), Lilyana Angelov(7), Sean P. Pitroda(7), Jeffrey Chin(7), Nicole A. Cipriani(7)